Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
a study on High Blood Pressure Interstitial Lung Disease Fibrosis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Vijay BalasubramanianJeffrey Golden, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at UCSF
- Vijay Balasubramanian
Vijay Balasubramanian, M.D. Clinical Professor of Medicine, UCSF Medical Director of Pulmonary Hypertension-Community Regional Medical Center Vijay Balasubramanian, M.D., specializes in pulmonary disease. He is board certified in Internal Medicine. His residency and fellowship training were completed at the Medical College of Wisconsin. - Jeffrey Golden, MD
Professor, Medicine. Authored (or co-authored) 185 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- United Therapeutics
- ID
- NCT02630316
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated